Author
Listed:
- Xiaona Li
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology)
- Nathan D. Winters
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology)
- Shubhi Pandey
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology)
- Colten Lankford
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology)
- Hannah M. Stoveken
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology)
- Emery Smith
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology)
- Chu-Ting Chang
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
The Scripps Research Institute)
- Stefano Zucca
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology)
- Louis Scampavia
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology)
- Timothy Spicer
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology)
- Kirill A. Martemyanov
(The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology
The Scripps Research Institute)
Abstract
The endogenous opioid system provides powerful control over emotions, nociception, and motivation among many other fundamental nervous system functions. Its major components include a panel of opioid peptides that activate four canonical inhibitory opioid receptors. However, its regulatory principles are not fully understood including the existence of additional receptors and other elements. In this study we report the identification of a receptor for the opioid peptide dynorphin. By conducting a screen of a custom library of neuropeptides, we found that orphan receptor GPR139 binds to and is activated by a series of dynorphin peptides. Unlike other opioid receptors, GPR139 couples to Gq/11 and avoids β-arrestin, providing excitatory signaling that homeostatically scales the inhibitory response of neurons to dynorphin. This introduces a non-canonical dynorphin receptor as an essential component of the opioid system.
Suggested Citation
Xiaona Li & Nathan D. Winters & Shubhi Pandey & Colten Lankford & Hannah M. Stoveken & Emery Smith & Chu-Ting Chang & Stefano Zucca & Louis Scampavia & Timothy Spicer & Kirill A. Martemyanov, 2025.
"Homeostatic scaling of dynorphin signaling by a non-canonical opioid receptor,"
Nature Communications, Nature, vol. 16(1), pages 1-16, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62133-x
DOI: 10.1038/s41467-025-62133-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-62133-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.